MedTrace Logo

Safety and Performance Evaluation of the Rapid Ring Device

NCT01152983 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-06-29

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety, performance and initial efficacy of the RapiDx device.

Conditions

  • Healthy

Interventions

DEVICE

Rapid Ring

Rapid Ring is a ring-shaped device that encircles the distal phalanx of the middle finger and blocks the arterial blood to quickly and passively withdraw blood following a finger stick, and to reduce the pain of the lancet.

Sponsors & Collaborators

  • RapiDx Ltd.

    lead INDUSTRY

Principal Investigators

  • Ella Naparstek, Prof. · Chairman of the Hematology Institute and the Department of Hematology and Bone Marrow Transplantation at Tel Aviv Sourasky Medical Center.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01152983 on ClinicalTrials.gov